ClinicalTrials.Veeva

Menu

LUPS-Lipids and Glucose Under Prospective Surveillance

A

Asklepios proresearch

Status

Completed

Conditions

Type 2 Diabetes
Metabolic Syndrome

Study type

Observational

Funder types

Other
Industry

Identifiers

NCT01313156
AKS#1833

Details and patient eligibility

About

Prospective, non-randomized cohort study to analyse genetic variations, dietary patterns, perceived stress and anxiety and early changes in lipid metabolism leading to the metabolic syndrome and type 2 diabetes

Full description

The LUPS-study is a collaboration between Asklepios Clinics Hamburg GmbH and University Clinic Hamburg Eppendorf, Germany. This study is assessing a multitude of serum biomarkers, anthropometrics, dietary habits, physical activity, perceived stress along with genetic information from "healthy workers" (25-60years) to better understand phenotype-genotype associations leading to MetS and type 2 diabetes.

Enrollment

1,962 patients

Sex

All

Ages

25 to 60 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • 25-60 years men and women willing to give consent

Exclusion criteria

  • diabetes (type 1 or 2)

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems